A detailed history of Legacy Financial Group, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Legacy Financial Group, Inc. holds 1,700 shares of DXCM stock, worth $188,649. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,700
Previous 1,714 0.82%
Holding current value
$188,649
Previous $213 Million 10.86%
% of portfolio
0.09%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$114.22 - $140.1 $1,599 - $1,961
-14 Reduced 0.82%
1,700 $236 Million
Q4 2023

Feb 13, 2024

BUY
$75.49 - $124.16 $129,389 - $212,810
1,714 New
1,714 $213 Million
Q2 2023

Aug 07, 2023

SELL
$112.47 - $130.98 $2,811 - $3,274
-25 Reduced 1.42%
1,739 $223 Million
Q1 2023

May 12, 2023

SELL
$104.0 - $122.92 $7,384 - $8,727
-71 Reduced 3.87%
1,764 $205 Million
Q4 2022

Feb 15, 2023

BUY
$84.98 - $122.67 $155,938 - $225,099
1,835 New
1,835 $208 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $42.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Legacy Financial Group, Inc. Portfolio

Follow Legacy Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Legacy Financial Group, Inc. with notifications on news.